2,6-difluoro-N-[4-[2-(hydroxymethyl)-2,8-dimethyl-4-oxo-4a,8a-dihydro-3H-chromen-7-yl]phenyl]benzamide
C25H23F2NO4 — CID 123565917
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2,6-difluoro-N-[4-[2-(hydroxymethyl)-2,8-dimethyl-4-oxo-4a,8a-dihydro-3H-chromen-7-yl]phenyl]benzamide
2,6-difluoro-N-[4-[2-(hydroxymethyl)-2,8-dimethyl-4-oxo-4a,8a-dihydro-3H-chromen-7-yl]phenyl]benzamide (PubChem CID 123565917) has the molecular formula C25H23F2NO4 and a molecular weight of 439.46 g/mol. Its IUPAC name is 2,6-difluoro-N-[4-[2-(hydroxymethyl)-2,8-dimethyl-4-oxo-4a,8a-dihydro-3H-chromen-7-yl]phenyl]benzamide.
Molecular Properties
| Compound Name | 2,6-difluoro-N-[4-[2-(hydroxymethyl)-2,8-dimethyl-4-oxo-4a,8a-dihydro-3H-chromen-7-yl]phenyl]benzamide |
|---|---|
| PubChem CID | 123565917 |
| Molecular Formula | C25H23F2NO4 |
| Molecular Weight | 439.46 g/mol |
| Exact Mass | 439.16 |
| IUPAC Name | 2,6-difluoro-N-[4-[2-(hydroxymethyl)-2,8-dimethyl-4-oxo-4a,8a-dihydro-3H-chromen-7-yl]phenyl]benzamide |
| SMILES | CC1=C(c2ccc(NC(=O)c3c(F)cccc3F)cc2)C=CC2C(=O)CC(C)(CO)OC12 |
| InChI | InChI=1S/C25H23F2NO4/c1-14-17(10-11-18-21(30)12-25(2,13-29)32-23(14)18)15-6-8-16(9-7-15)28-24(31)22-19(26)4-3-5-20(22)27/h3-11,18,23,29H,12-13H2,1-2H3,(H,28,31) |
| InChIKey | ROJLBPQGTYDYHD-UHFFFAOYSA-N |
| XLogP | 4.29 |
| TPSA | 75.63 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 439.46 |
| LogP ≤ 5 | 4.29 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123565917 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.